Targeted Therapy and Avelumab in Merkel Cell Carcinoma (GoTHAM)
NCT 04261855 Brief Summary 10.17 GoTHAM is intended as a signal-seeking, biomarker,…
Read more arrow_forwardNCT 04261855 Brief Summary 10.17 GoTHAM is intended as a signal-seeking, biomarker,…
Read more arrow_forwardNCT 05549297 Brief Summary The purpose of this study is to evaluate…
Read more arrow_forwardACTRN 12621000273886 Brief Summary The ADELE clinical trial seeks to improve outcomes…
Read more arrow_forwardNCT 04585750 Brief Summary The Phase 2 monotherapy portion of this study…
Read more arrow_forwardACTRN 12625000160437 Brief Summary This study aims to evaluate the feasibility and…
Read more arrow_forwardACTRN 12624001045505 Brief Summary The aim of this study is to evaluate…
Read more arrow_forwardNCT 05756322 Brief Summary The most common types of acute leukaemia are…
Read more arrow_forwardNCT 06520345 Brief Summary The purpose of this study is to evaluate…
Read more arrow_forwardNCT 06003621 Brief Summary This phase II study will explore the effect…
Read more arrow_forwardNCT 07082803 Brief Summary The primary purpose of this study is to…
Read more arrow_forwardNCT 05356741 Brief Summary This first-in-human (FIH) Phase 1 open-label multicenter dose-escalation…
Read more arrow_forwardACTRN 12620001264976 Brief Summary Malignant pleural mesothelioma (MPM) is a rare cancer…
Read more arrow_forwardACTRN 12623001221640 Brief Summary This research is conducted to initially diagnose Cancer…
Read more arrow_forwardNCT 05411133 Brief Summary This study aims to find out: The tolerability…
Read more arrow_forwardNCT 04589845 Brief Summary TAPISTRY is a Phase II, global, multicenter, open-label,…
Read more arrow_forward